Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-045422
Date:2021-07-01
Issuer: DENALI THERAPEUTICS INC. (DNLI)
Original Submission Date:

Reporting Person:

WATTS RYAN J.
C/O DENALI THERAPEUTICS INC.
161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-07-01 S 3,030 d $76.38 2,207,712 indirect f3
COMMON STOCK 2021-07-01 S 12,844 d $77.35 2,194,868 indirect f3
COMMON STOCK 2021-07-01 S 2,459 d $77.84 2,192,409 indirect f3
COMMON STOCK 2021-07-01 0 $0.00 156,691 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported by the reporting person were effected pursuant to a rule 10b5-1 trading plan.
f2 the sale price reported in column 4 of table i represents the weighted average sale price of the shares purchased ranging from $75.67 to $76.66 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
f3 the shares are held of record by the watts family 2015 trust dated july 7, 2015, for which the reporting person serves as trustee.
f4 the sale price reported in column 4 of table i represents the weighted average sale price of the shares purchased ranging from $76.67 to $77.665 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
f5 the sale price reported in column 4 of table i represents the weighted average sale price of the shares purchased ranging from $77.67 to $78.25 per share. upon request by the commission staff, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
f6 includes 156,691 restricted stock units.
WhaleWisdom Logo

Elevate your investments